Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Change in Receivables (2021 - 2025)

Senti Biosciences has reported Change in Receivables over the past 5 years, most recently at -$325000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 282.35% year-over-year to -$325000.0; the TTM value through Dec 2025 reached -$374000.0, down 895.74%, while the annual FY2025 figure was -$374000.0, 895.74% down from the prior year.
  • Change in Receivables for Q4 2025 was -$325000.0 at Senti Biosciences, up from -$1.9 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $1.9 million in Q4 2023 and troughed at -$1.9 million in Q3 2025.
  • A 5-year average of $75882.4 and a median of -$38000.0 in 2024 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 3774.36% in 2025 and fell as far as 1022.01% in 2025.
  • Year by year, Change in Receivables stood at $50000.0 in 2021, then soared by 162.0% to $131000.0 in 2022, then skyrocketed by 1384.73% to $1.9 million in 2023, then tumbled by 104.37% to -$85000.0 in 2024, then crashed by 282.35% to -$325000.0 in 2025.
  • Business Quant data shows Change in Receivables for SNTI at -$325000.0 in Q4 2025, -$1.9 million in Q3 2025, and $1.4 million in Q2 2025.